Literature DB >> 10862555

Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.

G M Williams1, M J Iatropoulos, A M Jeffrey.   

Abstract

To explore differences in mechanisms of carcinogenicity at low and high exposures, we have conducted a series of exposure-response studies of hepatocarcinogenesis in rats using 2 well-studied DNA-reactive carcinogens, 2-acetylaminofluorene and diethylnitrosamine. In these studies, we have used intraperitoneal injection or intragastric instillation to deliver exact doses during an initiation segment followed by phenobarbital as a liver tumor promoter to enhance manifestation of initiation. This protocol results in carcinogenicity comparable to that produced by lifetime exposure to the carcinogens. Our findings in these experiments provide evidence for the following: (a) formation of DNA adducts can be nonlinear, with a plateau at higher exposures; (b) cytotoxicity shows no-effect levels and is related to exposure; (c) compensatory hepatocyte proliferation shows no-effect levels and can be supralinear at high exposures; (d) formation of preneoplastic hepatocellular altered foci can show no-effect levels and appears supralinear at high exposures; (e) no-effect levels can exist for tumor development, and the exposure response can be supralinear. We interpret these findings to reflect thresholds for hepatocellular initiating effects of these carcinogens and exaggerated responses at high exposures attributable to cytotoxicity and compensatory hepatocyte proliferation. Such enhanced proliferation of hepatocytes harboring DNA damage likely results in an exaggerated yield of mutations in critical genes, leading to supralinear initiation of carcinogenesis. Thus, mechanisms differ between low and high exposures. Based on these observations, we suggest that linear extrapolation from high toxic exposures to postulated low-exposure effects of DNA-reactive carcinogens can yield overestimates. Such extrapolation must be supported by mechanistic information. The finding of no-effect levels provides a basis for understanding why low-level environmental exposures of humans to even DNA-reactive carcinogens may convey no cancer risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862555     DOI: 10.1177/019262330002800306

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  10 in total

1.  The camKK2/camKIV relay is an essential regulator of hepatic cancer.

Authors:  Fumin Lin; Kathrina L Marcelo; Kimal Rajapakshe; Cristian Coarfa; Adam Dean; Nathaniel Wilganowski; Holly Robinson; Eva Sevick; Karl-Dimiter Bissig; Lauren C Goldie; Anthony R Means; Brian York
Journal:  Hepatology       Date:  2015-05-09       Impact factor: 17.425

2.  Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression.

Authors:  Khairy M A Zoheir; Ahmed A Abd-Rabou; Gamaleldin I Harisa; Abdelkader E Ashour; Sheikh Fayaz Ahmad; Sabry M Attia; Saleh A Bakheet; Hala E Abdel-Hamied; Adel R Abd-Allah; Ashok Kumar
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization.

Authors:  Ryan M Kiefer; Stephen J Hunt; Santiago Pulido; Stephen Pickup; Emma E Furth; Michael C Soulen; Gregory J Nadolski; Terence P Gade
Journal:  J Vasc Interv Radiol       Date:  2017-05-09       Impact factor: 3.464

Review 4.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

Review 5.  Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

Authors:  Samuele De Minicis; Tatiana Kisseleva; Heather Francis; Gianluca Svegliati Baroni; Antonio Benedetti; David Brenner; Domenico Alvaro; Gianfranco Alpini; Marco Marzioni
Journal:  Dig Liver Dis       Date:  2012-11-22       Impact factor: 4.088

6.  Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.

Authors:  M Hatting; M Spannbauer; J Peng; M Al Masaoudi; G Sellge; Y A Nevzorova; N Gassler; C Liedtke; F J Cubero; C Trautwein
Journal:  Cell Death Dis       Date:  2015-03-05       Impact factor: 8.469

7.  Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.

Authors:  A S Arboatti; F Lambertucci; M G Sedlmeier; G Pisani; J Monti; M de L Álvarez; D E A Francés; M T Ronco; C E Carnovale
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

8.  Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.

Authors:  Sameh Saber; Amr Mahmoud; Noha Helal; Eman El-Ahwany; Rasha Abdelghany
Journal:  Open Access Maced J Med Sci       Date:  2018-06-06

9.  Lack of Hepatocarcinogenicity of Combinations of Low Doses of 2-amino-3, 8-dimethylimidazo[4,5- f ]quinoxaline and Diethylnitrosamine in Rats: Indication for the Existence of a Threshold for Genotoxic Carcinogens.

Authors:  Min Wei; Anna Kakehashi; Shotaro Yamano; Seiko Tamano; Tomoyuki Shirai; Hideki Wanibuchi; Shoji Fukushima
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

10.  Non-linear relationships between aflatoxin B₁ levels and the biological response of monkey kidney vero cells.

Authors:  Reuven Rasooly; Bradley Hernlem; Xiaohua He; Mendel Friedman
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.